Clinical Trials Directory

Trials / Unknown

UnknownNCT06173882

Moxibustion Reduces Symptoms and Improves Quality of Life in Patients With Allergic Rhinitis

The Therapeutic Effect and Standardization of Moxibustion in the Treatment of Allergic Rhinitis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Henan University of Traditional Chinese Medicine · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The objective of this randomized controlled clinical trial is to compare the therapeutic effect of moxibustion on allergic rhinitis. The main questions it aims to answer are: Based on randomized controlled trials, verify the effectiveness of moxibustion in treating allergic rhinitis Based on a real-time monitoring system for human surface temperature, discuss the differences in therapeutic effects of different moxibustion doses on allergic rhinitis

Detailed description

Allergic rhinitis has a high incidence and is difficult to cure, seriously affecting the quality of life of patients Compare the effects of different moxibustion durations on the clinical efficacy and body surface temperature of patients with allergic rhinitis, and preliminarily explore the impact of different moxibustion doses on the efficacy of heavy moxibustion treatment for allergic rhinitis, providing evidence-based basis for clinical practice.

Conditions

Interventions

TypeNameDescription
BEHAVIORALOrdinary moxibustion volume groupMoxibustion for 10 minutes per acupoint
BEHAVIORALFirst group of heavy moxibustionMoxibustion for 20 minutes per acupoint
BEHAVIORALSecond groups of heavy moxibustionMoxibustion for 30 minutes per acupoint

Timeline

Start date
2022-08-01
Primary completion
2024-08-01
Completion
2025-08-01
First posted
2023-12-18
Last updated
2023-12-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06173882. Inclusion in this directory is not an endorsement.